Tempus AI, Inc. (TEM)
Oxford Ledge is still expanding full research coverage of TEM. A live quote, fundamentals, and analysis are available in the app; the SEC-sourced material below is what we currently have indexed here.
Business summary
Tempus AI applies artificial intelligence to laboratory diagnostics and drug development by integrating clinical data across healthcare networks to improve precision medicine.
SEC filings
- 8-K Shareholder vote results 2026-05-22
- 8-K Entry into material agreement; Termination of material agreement; Creation of direct financial obligation; 3.02; Other material event; Financial statements and exhibits 2026-05-13
- 10-Q Quarterly financial report (unaudited) 2026-05-05
- 8-K Results of operations / financial condition; Regulation FD disclosure; Financial statements and exhibits 2026-05-05
- DEF 14A Proxy statement for shareholder vote 2026-04-07
Source: SEC EDGAR.
Insider activity
5 recent insider (SEC Form 4) filings on record for TEM. View the transactions in the terminal.
Source: SEC EDGAR (Form 4).
- Open TEM in the Oxford Ledge terminal — live quote, chart, and analysis in the app.
- Browse the covered-stock index
- Learn to analyze stocks yourself
The material above is drawn from public SEC EDGAR filings and is provided for educational purposes, not as investment advice. Live pricing and fundamentals are available in the terminal.